In the AML microenvironment, IL-10 increases the proportion of Breg cells, promotes the secretion of immunosuppressive factors (including IL-10 itself and TGF-β), and suppresses effector T-cell function, thereby facilitating tumor immune escape (45). The gene discussed is TGFB1; the disease is neoplasm.